Icahn School Of Medicine At Mount Sinai - Insider Trading & Ownership

Entity
Individual
Location
1 Gustave L. Levy Place, New York, NY
Summary
The estimated net worth of Icahn School Of Medicine At Mount Sinai is at least $220M dollars as of November 4, 2024. Icahn School Of Medicine At Mount Sinai is the 10%+ Owner of GeneDx Holdings Corp. and owns shares of GeneDx Holdings Corp. (WGS) stock worth about $215M. Icahn School Of Medicine At Mount Sinai is the 10%+ Owner of Renalytix plc and owns shares of Renalytix plc (RNLX) stock worth about $4.83M.
All Insider Reports
All Insider Reports

Ownership of Icahn School Of Medicine At Mount Sinai

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
WGS, WGSWW GeneDx Holdings Corp. 10%+ Owner $215M -$64.9M -23.2% Oct 31, 2024
RNLX, RTNXF Renalytix plc 10%+ Owner $4.83M Apr 24, 2024

Insider Transactions Reported by Icahn School Of Medicine At Mount Sinai:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.